# Reducing Acute Severe Respiratory Events in Health Care Workers During the Covid-19 Pandemic With OM85

> **NCT04496245** · PHASE3 · COMPLETED · sponsor: **The University of Queensland** · enrollment: 59 (actual)

## Conditions studied

- Respiratory Viral Infection
- Covid19

## Interventions

- **DRUG:** Broncho-Vaxom®

## Key facts

- **NCT ID:** NCT04496245
- **Lead sponsor:** The University of Queensland
- **Sponsor class:** OTHER
- **Phase:** PHASE3
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2020-08-24
- **Primary completion:** 2021-06-30
- **Final completion:** 2021-09-30
- **Target enrollment:** 59 (ACTUAL)
- **Last updated:** 2022-03-09

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04496245

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04496245, "Reducing Acute Severe Respiratory Events in Health Care Workers During the Covid-19 Pandemic With OM85". Retrieved via AI Analytics 2026-05-31 from https://api.ai-analytics.org/clinical/NCT04496245. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*